An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in ...
Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...
The health reporter Kim Schewitz often feels tired, and hoped tracking her blood sugar levels using a continuous glucose ...
Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.
South Wales Argus on MSN
Report: Continuous glucose monitoring helps manage blood sugar levels
A new report has found that continuous glucose monitoring has benefits beyond diabetes care ...
The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.
The initiative aims to move beyond single-parameter glucose tracking by integrating key cardio-metabolic biomarkers directly ...
Continuous glucose monitoring is associated with lower all-cause mortality in older adults with diabetes and ADRD compared with self-monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results